Global Malaria Vaccines Market by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 138092
  • calendar_today Published On: Jan, 2019
  • file_copy Pages: 132
  • list Pharmaceuticals and Healthcare

Malaria Vaccines are used for malaria treatment.Malaria is a severe and widespread disease caused by a parasitic infection by protozoan Plasmodium when transmitted by various species of anopheles mosquitoes.

Scope of the Report:

This report focuses on the Malaria Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The growing incidence of malaria globally and major players pledging for low profit margin over vaccines is expected to boost growth of the market for malaria vaccines market.

The worldwide market for Malaria Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach million US$ in 2023, from million US$ in 2017, according to a new study.

Market Segment by Manufacturers, this report covers

GlaxoSmithKline plc

Sanaria Inc

Nobelpharma Co

Sumaya Biotech

GenVec

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Pre-Erythrocytic Vaccine

Erythrocytic Vaccine

Multi-antigen Vaccine

Market Segment by Applications, can be divided into

Hospitals

Clinics

Community Centers

There are 15 Chapters to deeply display the global Malaria Vaccines market.

Chapter 1, to describe Malaria Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Malaria Vaccines, with sales, revenue, and price of Malaria Vaccines, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Malaria Vaccines, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Malaria Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Malaria Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Malaria Vaccines Introduction

1.2 Market Analysis by Type

1.2.1 Pre-Erythrocytic Vaccine

1.2.2 Erythrocytic Vaccine

1.2.3 Multi-antigen Vaccine

1.3 Market Analysis by Applications

1.3.1 Hospitals

1.3.2 Clinics

1.3.3 Community Centers

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 GlaxoSmithKline plc

2.1.1 Business Overview

2.1.2 Malaria Vaccines Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 GlaxoSmithKline plc Malaria Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Sanaria Inc

2.2.1 Business Overview

2.2.2 Malaria Vaccines Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Sanaria Inc Malaria Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Nobelpharma Co

2.3.1 Business Overview

2.3.2 Malaria Vaccines Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Nobelpharma Co Malaria Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Sumaya Biotech

2.4.1 Business Overview

2.4.2 Malaria Vaccines Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Sumaya Biotech Malaria Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 GenVec

2.5.1 Business Overview

2.5.2 Malaria Vaccines Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 GenVec Malaria Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Malaria Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Malaria Vaccines Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Malaria Vaccines Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Malaria Vaccines Manufacturer Market Share in 2017

3.3.2 Top 6 Malaria Vaccines Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Malaria Vaccines Market Analysis by Regions

4.1 Global Malaria Vaccines Sales, Revenue and Market Share by Regions

4.1.1 Global Malaria Vaccines Sales and Market Share by Regions (2013-2018)

4.1.2 Global Malaria Vaccines Revenue and Market Share by Regions (2013-2018)

4.2 North America Malaria Vaccines Sales and Growth Rate (2013-2018)

4.3 Europe Malaria Vaccines Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Malaria Vaccines Sales and Growth Rate (2013-2018)

4.5 South America Malaria Vaccines Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Malaria Vaccines Sales and Growth Rate (2013-2018)

5 North America Malaria Vaccines by Countries

5.1 North America Malaria Vaccines Sales, Revenue and Market Share by Countries

5.1.1 North America Malaria Vaccines Sales and Market Share by Countries (2013-2018)

5.1.2 North America Malaria Vaccines Revenue and Market Share by Countries (2013-2018)

5.2 United States Malaria Vaccines Sales and Growth Rate (2013-2018)

5.3 Canada Malaria Vaccines Sales and Growth Rate (2013-2018)

5.4 Mexico Malaria Vaccines Sales and Growth Rate (2013-2018)

6 Europe Malaria Vaccines by Countries

6.1 Europe Malaria Vaccines Sales, Revenue and Market Share by Countries

6.1.1 Europe Malaria Vaccines Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Malaria Vaccines Revenue and Market Share by Countries (2013-2018)

6.2 Germany Malaria Vaccines Sales and Growth Rate (2013-2018)

6.3 UK Malaria Vaccines Sales and Growth Rate (2013-2018)

6.4 France Malaria Vaccines Sales and Growth Rate (2013-2018)

6.5 Russia Malaria Vaccines Sales and Growth Rate (2013-2018)

6.6 Italy Malaria Vaccines Sales and Growth Rate (2013-2018)

7 Asia-Pacific Malaria Vaccines by Countries

7.1 Asia-Pacific Malaria Vaccines Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Malaria Vaccines Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Malaria Vaccines Revenue and Market Share by Countries (2013-2018)

7.2 China Malaria Vaccines Sales and Growth Rate (2013-2018)

7.3 Japan Malaria Vaccines Sales and Growth Rate (2013-2018)

7.4 Korea Malaria Vaccines Sales and Growth Rate (2013-2018)

7.5 India Malaria Vaccines Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Malaria Vaccines Sales and Growth Rate (2013-2018)

8 South America Malaria Vaccines by Countries

8.1 South America Malaria Vaccines Sales, Revenue and Market Share by Countries

8.1.1 South America Malaria Vaccines Sales and Market Share by Countries (2013-2018)

8.1.2 South America Malaria Vaccines Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Malaria Vaccines Sales and Growth Rate (2013-2018)

8.3 Argentina Malaria Vaccines Sales and Growth Rate (2013-2018)

8.4 Colombia Malaria Vaccines Sales and Growth Rate (2013-2018)

9 Middle East and Africa Malaria Vaccines by Countries

9.1 Middle East and Africa Malaria Vaccines Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Malaria Vaccines Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Malaria Vaccines Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Malaria Vaccines Sales and Growth Rate (2013-2018)

9.3 UAE Malaria Vaccines Sales and Growth Rate (2013-2018)

9.4 Egypt Malaria Vaccines Sales and Growth Rate (2013-2018)

9.5 Nigeria Malaria Vaccines Sales and Growth Rate (2013-2018)

9.6 South Africa Malaria Vaccines Sales and Growth Rate (2013-2018)

10 Global Malaria Vaccines Market Segment by Type

10.1 Global Malaria Vaccines Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Malaria Vaccines Sales and Market Share by Type (2013-2018)

10.1.2 Global Malaria Vaccines Revenue and Market Share by Type (2013-2018)

10.2 Pre-Erythrocytic Vaccine Sales Growth and Price

10.2.1 Global Pre-Erythrocytic Vaccine Sales Growth (2013-2018)

10.2.2 Global Pre-Erythrocytic Vaccine Price (2013-2018)

10.3 Erythrocytic Vaccine Sales Growth and Price

10.3.1 Global Erythrocytic Vaccine Sales Growth (2013-2018)

10.3.2 Global Erythrocytic Vaccine Price (2013-2018)

10.4 Multi-antigen Vaccine Sales Growth and Price

10.4.1 Global Multi-antigen Vaccine Sales Growth (2013-2018)

10.4.2 Global Multi-antigen Vaccine Price (2013-2018)

11 Global Malaria Vaccines Market Segment by Application

11.1 Global Malaria Vaccines Sales Market Share by Application (2013-2018)

11.2 Hospitals Sales Growth (2013-2018)

11.3 Clinics Sales Growth (2013-2018)

11.4 Community Centers Sales Growth (2013-2018)

12 Malaria Vaccines Market Forecast (2018-2023)

12.1 Global Malaria Vaccines Sales, Revenue and Growth Rate (2018-2023)

12.2 Malaria Vaccines Market Forecast by Regions (2018-2023)

12.2.1 North America Malaria Vaccines Market Forecast (2018-2023)

12.2.2 Europe Malaria Vaccines Market Forecast (2018-2023)

12.2.3 Asia-Pacific Malaria Vaccines Market Forecast (2018-2023)

12.2.4 South America Malaria Vaccines Market Forecast (2018-2023)

12.2.5 Middle East and Africa Malaria Vaccines Market Forecast (2018-2023)

12.3 Malaria Vaccines Market Forecast by Type (2018-2023)

12.3.1 Global Malaria Vaccines Sales Forecast by Type (2018-2023)

12.3.2 Global Malaria Vaccines Market Share Forecast by Type (2018-2023)

12.4 Malaria Vaccines Market Forecast by Application (2018-2023)

12.4.1 Global Malaria Vaccines Sales Forecast by Application (2018-2023)

12.4.2 Global Malaria Vaccines Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Malaria Vaccines Picture

Table Product Specifications of Malaria Vaccines

Figure Global Sales Market Share of Malaria Vaccines by Types in 2017

Table Ma

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery